Windpact has launched the Crash Cloud system, with the aim of reducing rates of concussion. The Crash Cloud system is made up of three elements: Wind Springs, Impact Vents and Refresh Vents.
Researchers at The Rockefeller University (New York City, USA) have described a new technique that captures a detailed snapshot of global activity in the mouse brain.
A new bill introduced to the US Senate by Senator Dan Coats seeks to address the gap between the US Food and Drug Administration (FDA)’s priority review process for breakthrough medical devices, and the Centers for Medical and Medicare Services’ (CMS) review system for reimbursement.
The Netherlands presidency of the European Council and representatives of the European Parliament have reached a political agreement on two draft regulations for medical devices. The new regulations are aimed at ensuring that medical devices and in vitro diagnostic medical devices are safe while allowing patients to benefit of innovative health care solutions in a timely manner. However, the agreement is subject to the approval by the Council’s Permanent Representatives Committee and of the Parliament’s ENVI committee.
A study recently published in the journal Neuromodulation has concluded that using spinal cord stimulation devices, paraesthesia are not necessary for pain relief and may actually increase attention to pain.
A new study published in The New England Journal of Medicine has demonstrated both the importance of, and the challenges associated with, treating people who are at high risk of a stroke.
Boston Scientific Corporation has launched the Precision Montage MRI spinal cord stimulator system after receiving approval from the US Food and Drug Administration (FDA).
Mainstay Medical International has received CE mark approval for ReActiv8, its proprietary implantable neurostimulation system designed to treat disabling chronic low back pain.
Data from the first 500 patients was presented at the European Stroke Organization Conference (ESOC) in Barcelona, Spain, by Antonin Krajina (Hradec Kralove, Czech Republic). The data showed that 9 out of 10 patients had complete or near complete removal of the clot and over half were functionally independent. In a subset of these 500 patients, over 58% were functionally independent at 90 days. This closely matches the population of the interventional arm in a meta-analysis of randomised clinical trials for ischaemic stroke, according to a company release.
Winner of the DePuy Synthes Resident Craniofacial Award, Ryan Patrick Morton presented his research, Timing of Cranioplasty: A 10-year Single-center Analysis of 754 Patients, during the 2016 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting.
Predicting an increase in demand for the company’s technology, a Stimwave press release notes that this alliance will enables Stimwave to leverage Kairuku’s infrastructure platform and established relationships in the medical field to expand delivery and support for its implantable devices to clinicians, surgery centres and hospitals across the USA.
The US Food and Drug Administration (FDA) has approved Medtronic’s Specify SureScan MRI surgical leads, which are indicated for use as part of Medtronic implanted neurostimulation systems for chronic pain.
University of Texas (UT) Southwestern Medical Center has joined a consortium of seven leading universities to develop new technologies to improve memory in people with traumatic brain injury, mild cognitive impairment, epilepsy, and Alzheimer’s disease.
Researchers have linked high levels of C-reactive protein (CRP) with increased risk for recurrent ischaemic stroke. Already used to measure people’s risk of developing coronary artery disease, the research suggests it could be a useful tool for ischaemic stroke patients as well.
The UK National Institute for Health and Care Excellence (NICE) has published updated guidance for the UK National Health Service (NHS) on the use of mechanical clot retrieval to treat patients who have had an ischaemic stroke.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos